Início > BIGG > Resultado da busca

    Resultados: 17

    Guidance for national tuberculosis programmes on the management of tuberculosis in children

    World Health Organization.
    This Guideline outlines the purpose and the target audience of the second edition of Guidance for national tuberculosis programmes on the management of tuberculosis in children. It discusses the difference between TB in children and adolescents and TB in adults and provides an estimate of the burden of c...
    Antituberculosos/administração & dosagem, Tuberculose/tratamento farmacológico, Tuberculose/prevenção & controle, Tuberculose Resistente a Múltiplos Medicamentos/prevenção & controle, Tuberculose Resistente a Múltiplos Medicamentos/tratamento farmacológico, Tuberculose/diagnóstico, Quimioterapia Combinada
    Texto completo

    The use of bedaquiline in the treatment of multidrug-resistant tuberculosis: Interim policy guidance

    World Health Organization.
    WHO estimates that up to half a million new cases of multidrug-resistant tuberculosis (MDR-TB) occur worldwide, each year. Current treatment regimens for MDR-TB present many challenges: treatment lasts 20 months or more, requiring daily administration of drugs that are more toxic, less effective, and far...
    Tuberculose Resistente a Múltiplos Medicamentos/tratamento farmacológico, Resultado do Tratamento, Antituberculosos/uso terapêutico, Diarilquinolinas/uso terapêutico
    Texto completo (link principal)     Texto completo (link alternativo)    

    Guidelines for the programmatic management of drug-resistant tuberculosis – 2011 update

    World Health Organization.
    This 2011 update of Guidelines for the programmatic management of drug-resistant tuberculosis is intended as a tool for use by public health professionals working in response to the Sixty-second World Health Assembly’s resolution on prevention and control of multidrug-resistant tuberculosis and extensi...
    Tuberculose Resistente a Múltiplos Medicamentos/tratamento farmacológico, Tuberculose Resistente a Múltiplos Medicamentos/prevenção & controle, Antituberculosos/administração & dosagem, Infecções por HIV/tratamento farmacológico, Terapia Antirretroviral de Alta Atividade
    Texto completo

    Noncommercial culture and drug-susceptibility testing methods for screening patients at risk for multidrug-resistant tuberculosis: policy statement

    World Health Organization.
    Commercial liquid culture systems and molecular line-probe assays have been endorsed by the World Health Organization (WHO) as gold standards for rapid detection of multidrug-resistant (MDR) tuberculosis (TB); however, because of technical complexity, cost and the requirement for sophisticated laboratory...
    Tuberculose Resistente a Múltiplos Medicamentos, Antituberculosos, Testes de Sensibilidade Microbiana, Mycobacterium tuberculosis/isolamento & purificação
    Texto completo

    Treatment of tuberculosis: guidelines, 4th edition

    World Health Organization.
    This is fourth edition of Treatment of tuberculosis: guidelines, adhering fully to the new WHO process for evidence-based guidelines. Several important recommendations are being promoted in this new edition. First, the recommendation to discontinue the regimen based on just 2 months of rifampicin (2HRZE...
    Antituberculosos/administração & dosagem, Tuberculose Pulmonar/tratamento farmacológico, Programas Nacionais de Saúde, Cooperação do Paciente, Antituberculosos/uso terapêutico
    Texto completo

    Management of MDR-TB: a field guide: a companion document to guidelines for programmatic management of drug-resistant tuberculosis: integrated management of adolescent and adult illness (‎IMAI)‎

    World Health Organization.
    Multidrug-resistant tuberculosis (MDR-TB) and extensively drug-resistant tuberculosis (XDR-TB) increasingly occur in resource-constrained settings. In the context of a national response to MDR- and XDR-TB, health workers in TB clinics (in district hospitals and some accredited health centres) will need t...
    Tuberculose/terapia, Tuberculose Resistente a Múltiplos Medicamentos/tratamento farmacológico, Antituberculosos/administração & dosagem, Terapia Diretamente Observada/métodos, Prestação Integrada de Cuidados de Saúde/organização & administração, Terapia Antirretroviral de Alta Atividade
    Texto completo